Oxaliplatin-induced immune hemolytic anemia: a case report and review of the literature

被引：7

作者：

Cobo, Francesc ^{[1
]}

De Celis, Guillern

Pereira, Arturo

Latorre, Xavier

Pujadas, Jaume

Albiol, Santiago

机构：

[1] Hosp Ntra Sra, Oncohematol Unit, De Meritxell, Escaldes Engord, Andorra

[2] Hosp Ntra Sra, Dept Internal Med, De Meritxell, Escaldes Engord, Andorra

[3] Hosp Clin Barcelona, Immunohematol Unit, Dept Hemotherapy & Hemostasis, Barcelona, Spain

来源：

ANTI-CANCER DRUGS | 2007年 / 18卷 / 08期

关键词：

chemotherapy; colorectal cancer; immune cytopenia;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

We report a 59-year-old woman diagnosed with metastasic colorectal cancer who developed immune hemolytic anemia during FOLFOX chemotherapy (oxaliplatin/leucovorin/5-fluorouracil). lmmunohematologic studies demonstrated that immune hemolysis was oxaliplatin-mediated. On the basis of this case and in a review of the literature in which 13 cases of previously reported oxaliplatin-induced immune cytopenia have been identified, we suggest some clinical clues regarding the use of oxaliplatin in cancer patients.

引用

页码：973 / 976

页数：4

共 20 条

[1]

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer [J].

Andre, T ;

Boni, C ;

Mounedji-Boudiaf, L ;

Navarro, M ;

Tabernero, J ;

Hickish, T ;

Topham, C ;

Zaninelli, M ;

Clingan, P ;

Bridgewater, J ;

Tabah-Fisch, I ;

de Gramont, A .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) :2343-2351

[2]

Adjuvant chemotherapy of stage III colon cancer [J].

Benson, AB .

SEMINARS IN ONCOLOGY, 2005, 32 (06) :S74-S77

[3]

An immediate hemolytic reaction induced by repeated administration of oxaliplatin [J].

Chen, VMY ;

Thrift, KM ;

Morel-Kopp, MC ;

Jackson, D ;

Ward, CM ;

Flower, RL .

TRANSFUSION, 2004, 44 (06) :838-843

[4]

Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin [J].

Curtis, BR ;

Kaliszewski, J ;

Marques, MB ;

Saif, MW ;

Nabelle, L ;

Blank, J ;

McFarland, JG ;

Aster, RH .

AMERICAN JOURNAL OF HEMATOLOGY, 2006, 81 (03) :193-198

[5]

Oxaliplatin-induced haemolytic anaemia [J].

Desrame, J ;

Broustet, H ;

de Tailly, PD ;

Girard, D ;

Saissy, JM .

LANCET, 1999, 354 (9185) :1179-1180

[6]

Dold FG, 2003, ANN INTERN MED, V139, P156

[7]

Oxaliplatin-induced Evan's syndrome [J].

Earle, CC ;

Chen, WY ;

Ryan, DP ;

Mayer, RJ .

BRITISH JOURNAL OF CANCER, 2001, 84 (03) :441-441

[8]

Immunohemolytic anemia following oxaliplatin administration [J].

Garufi, C ;

Vaglio, S ;

Brienza, S ;

Conti, L ;

D'Attino, RM ;

Girelli, G ;

Terzoli, E .

ANNALS OF ONCOLOGY, 2000, 11 (04) :497-497

[9]

CISPLATIN-INDUCED HEMOLYSIS [J].

GETAZ, EP ;

BECKLEY, S ;

FITZPATRICK, J ;

DOZIER, A .

NEW ENGLAND JOURNAL OF MEDICINE, 1980, 302 (06) :334-335

[10]

Two potential mechanisms of oxaliplatin-induced haemolytic anaemia in a single patient [J].

Hofheinz, RD ;

Nguyen, XD ;

Buchheidt, D ;

Kerowgan, M ;

Hehlmann, R ;

Hochhaus, A .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 53 (03) :276-277

← 1 2 →